Jci_page_head_homepage_01 Jci_page_head_homepage_02
Xue-Feng Bai, Jinqing Liu, Ou Li, Pan Zheng, Yang Liu
Published in Volume 111, Issue 10
J Clin Invest. 2003; 111(10):1487–1496 doi:10.1172/JCI17656
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

Mutations in the P1A epitope abolished or drastically reduced T cell recognition of the antigen. (a) The AA sequences of the peptides used in the study, with the altered AA shown in bold. (b) Proliferation of transgenic T cells in response to either wild-type or mutant P1A peptide. (c) Cytolysis of P388D1 target cells pulsed with given concentrations of wild-type, mutant, or unrelated control H-2Ld–binding peptides. E/T = 10. (d) P1A mutants lack antagonistic activity for the P1CTL. Activated P1A-specific T cells were used as effectors. The target cells were preincubated with a mixture of wild-type P1A (10 ng/ml) and the indicated concentrations of mutant or wild-type P1A or control peptides. E/T = 10. Data shown were from a 6-hour 51Cr-release assay and are representative of three to five independent experiments. Ctrl, control.